allele carriers compared to the wildtype CYP2C19 group during omeprazole (difference PRI 16.7%; CI95 3.7-29.7%; P=0.014) and pantoprazole use (difference PRI 17.4%; CI95 2.4-32.5%; P=0.025).ConclusionsIn this study switching from omeprazole to pantoprazole resulted in better clopidogrel response...
METHODS: This observational, multicentre study conducted in the Netherlands included primary-care patients being treated with a proton pump inhibitor (PPI) [omeprazole, pantoprazole, rabeprazole or lansoprazole] for GORD who were switched to esomeprazole by their physician. After a median of 28 days'...
Methods: This observational, multicentre study conducted in the Netherlands included primary-care patients being treated with a proton pump inhibitor (PPI) [omeprazole, pantoprazole, rabeprazole or lansoprazole] for GORD who were switched to esomeprazole by their physician. After a median of 28 days'...